Keywords: Canada, Patented drug sales, Rx&D, R&D, Medicine prices, PMPRB

Sales of patented drug products in Canada flat due to lack of new high-volume blockbusters

Article | 25 June 2012

In 2011, sales of patented drug products in Canada increased toC$13.1 billion ($12.8 billion) from C$12.9 billion in 2010, a rise of 1.7%, according ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in